The PSTI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSTI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PSTI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PSTI Detailed Price Forecast - CNN Money||View PSTI Detailed Summary - Google Finance|
|View PSTI Detailed Summary - Yahoo! Finance||View PSTI Stock Research & Analysis - Zacks.com|
|View PSTI Trends & Analysis - Trade-Ideas||View PSTI Major Holders - Barrons|
|View PSTI Call Transcripts - NASDAQ||View PSTI Breaking News & Analysis - Seeking Alpha|
|View PSTI Annual Report - CompanySpotlight.com||View PSTI OTC Short Report - OTCShortReport.com|
|View PSTI Fundamentals - TradeKing||View PSTI SEC Filings - Bar Chart|
|View Historical Prices for PSTI - The WSJ||View Performance/Total Return for PSTI - Morningstar|
|View the Analyst Estimates for PSTI - MarketWatch||View the Earnings History for PSTI - CNBC|
|View the PSTI Earnings - StockMarketWatch||View PSTI Buy or Sell Recommendations - MacroAxis|
|View the PSTI Bullish Patterns - American Bulls||View PSTI Short Pain Metrics - ShortPainBot.com|
|View PSTI Stock Mentions - StockTwits||View PSTI Stock Mentions - PennyStockTweets|
|View PSTI Stock Mentions - Twitter||View PSTI Investment Forum News - Investor Hub|
|View PSTI Stock Mentions - Yahoo! Message Board||View PSTI Stock Mentions - Seeking Alpha|
|View Insider Transactions for PSTI - SECform4.com||View Insider Transactions for PSTI - Insider Cow|
|View PSTI Major Holdings Summary - CNBC||View Insider Disclosure for PSTI - OTC Markets|
|View Insider Transactions for PSTI - Yahoo! Finance||View Institutional Holdings for PSTI - NASDAQ|
|View PSTI Stock Insight & Charts - FinViz.com||View PSTI Investment Charts - StockCharts.com|
|View PSTI Stock Overview & Charts - BarChart||View PSTI User Generated Charts - Trading View|
What does Pluristem Therapeutics Inc’s (NASDAQ:PSTI) Balance Sheet Tell Us About Its Future?
Posted on Thursday September 20, 2018
Pluristem Therapeutics Inc (NASDAQ:PSTI), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is PSTIRead More...
Pluristem Initiates Two Pivotal Phase III Studies in Israel
Posted on Wednesday August 08, 2018
HAIFA, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading developer of placenta-based cell therapy products, announced today that Israel’s Ministry of Health has cleared the Company to commence patient recruitment in Israel for two ongoing pivotal Phase III trials of PLX-PAD cell therapy, one for the treatment of Critical Limb Ischemia (CLI) and another for the treatment of muscle injury following hip fracture surgery. Both trials have been accepted to accelerated approval pathways and have received a total of $16.7 million in grants from the European Union’s Horizon 2020 Program. “We are pleased to open clinical sites in Israel for both of our ongoing pivotal Phase III studies.
Pluristem Therapeutics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Posted on Tuesday July 31, 2018
With hundreds of biotech stocks all assuring big prospects, building a portfolio of truly transformative medicine makers is a feat. B. Riley FBR said it's found two winners. The Analyst Analyst George ...
Pluristem Granted Key Patent in Japan for Treatment of GI Following Acute Radiation Exposure
Posted on Thursday July 26, 2018
Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading developer of placenta-based cell therapy products, announced today that the Japan Patent Office has granted Pluristem a patent for the treatment of Acute Radiation Syndrome (ARS) and its impact on the gastrointestinal tract. The patent titled “Methods for Treating Radiation or Chemical Injury” relates to intramuscular (IM) administration of adherent stromal cells, cultured under three-dimensional culturing conditions, for mitigating intestinal damage in patients that have been exposed to radiation or chemotherapy.